Published in J Clin Psychopharmacol on April 01, 2009
Distinct molecular phenotypes in male and female schizophrenia patients. PLoS One (2013) 0.93
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry (2014) 0.91
A comparison of cardiovascular risk factors for ten antipsychotic drugs in clinical practice. Neuropsychiatr Dis Treat (2013) 0.77
Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review. Neurol Ther (2016) 0.75
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature (2012) 8.10
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment. Am J Psychiatry (2014) 3.98
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry (2004) 2.92
Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry (2012) 2.79
Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet (2011) 2.48
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs. PLoS Genet (2013) 2.08
Up-regulation of NOTCH4 gene expression in bipolar disorder. Am J Psychiatry (2012) 2.04
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J Neurosci (2002) 2.01
Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res (2010) 1.98
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry (2011) 1.94
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
The impact of divergence time on the nature of population structure: an example from Iceland. PLoS Genet (2009) 1.89
Early detection of the first episode of schizophrenia and suicidal behavior. Am J Psychiatry (2006) 1.85
Brain expressed microRNAs implicated in schizophrenia etiology. PLoS One (2007) 1.85
A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations. Proc Natl Acad Sci U S A (2009) 1.84
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord (2009) 1.74
Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry (2010) 1.73
Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care (2010) 1.59
Sex-dependent association of common variants of microcephaly genes with brain structure. Proc Natl Acad Sci U S A (2009) 1.55
Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull (2009) 1.51
Association analysis of schizophrenia on 18 genes involved in neuronal migration: MDGA1 as a new susceptibility gene. Am J Med Genet B Neuropsychiatr Genet (2008) 1.50
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol (2011) 1.49
[Compulsory admissions for observation in emergency psychiatric departments--discharge next day?]. Tidsskr Nor Laegeforen (2003) 1.47
Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr (2008) 1.43
The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull (2007) 1.41
Specific personality traits evoke different countertransference reactions: an empirical study. J Nerv Ment Dis (2008) 1.40
A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord (2010) 1.40
Correction: Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate. PLoS Genet (2015) 1.39
[Misleading about insulin administration to patients with diabetes]. Tidsskr Nor Laegeforen (2005) 1.39
[Antidiabetics which affect the incretin system]. Tidsskr Nor Laegeforen (2008) 1.38
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry (2011) 1.36
The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry (2007) 1.34
Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry (2012) 1.32
High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a population-based 18-year follow-up study. Arterioscler Thromb Vasc Biol (2005) 1.27
At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry (2011) 1.26
Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord (2008) 1.22
Selective aggregation of self-disorders in first-treatment DSM-IV schizophrenia spectrum disorders. J Nerv Ment Dis (2012) 1.17
Early detection of first-episode psychosis: the effect on 1-year outcome. Schizophr Bull (2006) 1.17
Day treatment of patients with personality disorders: experiences from a Norwegian treatment research network. J Pers Disord (2003) 1.16
Premorbid adjustment in first-episode non-affective psychosis: distinct patterns of pre-onset course. Br J Psychiatry (2004) 1.15
Promoting physical activity in a low-income multiethnic district: effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease: a community intervention reducing inactivity. Diabetes Care (2006) 1.15
Prevention of negative symptom psychopathologies in first-episode schizophrenia: two-year effects of reducing the duration of untreated psychosis. Arch Gen Psychiatry (2008) 1.13
Perceived discrimination is associated with severity of positive and depression/anxiety symptoms in immigrants with psychosis: a cross-sectional study. BMC Psychiatry (2011) 1.11
[Prevalence of diabetes mellitus in Norway]. Tidsskr Nor Laegeforen (2004) 1.08
A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet (2010) 1.08
Meta-analysis of heterogeneous data sources for genome-scale identification of risk genes in complex phenotypes. Genet Epidemiol (2011) 1.08
Risk factors for drug addiction and its outcome. A follow-up study over 25 years. Nord J Psychiatry (2003) 1.07
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol (2011) 1.07
Linkage-disequilibrium-based binning affects the interpretation of GWASs. Am J Hum Genet (2012) 1.07
The TIPS study and bias: replies to Dr Amos. Aust N Z J Psychiatry (2012) 1.07
Determinants and prognostic implications of cardiac troponin T measured by a sensitive assay in type 2 diabetes mellitus. Cardiovasc Diabetol (2010) 1.07
The validity of d prime as a working memory index: results from the "Bergen n-back task". J Clin Exp Neuropsychol (2010) 1.06
The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse. Schizophr Res (2007) 1.05
The genetic structure of the Swedish population. PLoS One (2011) 1.05
The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord (2011) 1.04
Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease. J Neurochem (2005) 1.04
Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry (2004) 1.03
Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. J Clin Psychopharmacol (2010) 1.02
Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia? J Int Neuropsychol Soc (2008) 1.01
A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. J Clin Psychiatry (2010) 1.00
Delusions are associated with poor cognitive insight in schizophrenia. Schizophr Bull (2009) 1.00
Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr Res (2008) 1.00
Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res (2011) 1.00
First-episode psychosis: diagnostic stability over one and two years. Psychopathology (2008) 1.00
Measuring cognitive insight in schizophrenia and bipolar disorder: a comparative study. BMC Psychiatry (2007) 0.99